ARQ GROUP (ASX: ARQ)Non-Executive Director Appointment – Mr Karl Siegling
Arq Group Ltd today announces the appointment of Mr Karl Siegling, as a non-executive Director of the Board, effective 23 August 2019.Mr Siegling has over 25 years investment experience in the financial sector both in Australia and overseas.Mr Siegling has been Chairman and Managing Director of ASX listed Cadence Capital Limited and unlisted Cadence Asset Management Pty Limited (Collectively Cadence) for over 16 years.
Posted on the ARQ forum website as well.
So is Karl Seigerlings appointment good for the ARQ board, or good for Karl Seigerling ?
His involvement with ARQ and him taking a significant holding in ARQ on behalf of CDM shareholders, certainly hasn’t been good for CDM shareholders.
This may be an attempt to redeem himself and in the process improve the price of ARQ and thus CDM.
One has to wonder if this a response to the significant loss by CDM shareholders as a consequence of Mr Seigerlings rash investment in ARQ (at one time holding almost 18% of the portfolio in ARQ) or part of a pre planned exercise ?
Holding almost 18% of the portfolio in ARQ wasn’t in the plan for CDM shareholders, I wonder if his move on toto the board was “planned” or was a move out of necessity ? After all, from 18% of the CDM portfolio in ARQ to approx 4% without selling a share is a significant fall in wealth and value. It’s OK for Karl, now he appears to being paid for 2 board appointments, or is his appointment “pro bono” ?
I freely admit to being a disgruntled CDM shareholder, but see all these things going on without any advice or reference to CDM shareholders who appear to have been treated like mushrooms.
- Forums
- ASX - By Stock
- CDM
- Karl Seigerling on the board of ARQ
Karl Seigerling on the board of ARQ
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CDM (ASX) to my watchlist
(20min delay)
|
|||||
Last
75.5¢ |
Change
0.005(0.67%) |
Mkt cap ! $224.8M |
Open | High | Low | Value | Volume |
76.0¢ | 76.0¢ | 75.5¢ | $115.4K | 152.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 81062 | 75.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
76.0¢ | 41674 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 71062 | 0.750 |
3 | 32686 | 0.745 |
3 | 29210 | 0.740 |
4 | 69787 | 0.735 |
4 | 50070 | 0.730 |
Price($) | Vol. | No. |
---|---|---|
0.760 | 41674 | 4 |
0.765 | 87000 | 7 |
0.770 | 205137 | 5 |
0.775 | 10820 | 2 |
0.780 | 4563 | 2 |
Last trade - 15.53pm 10/10/2024 (20 minute delay) ? |
Featured News
CDM (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online